The Effect of Chronic 5-Alpha Reductase Inhibition on Clinically Apparent and Silent Cardiovascular Events

    October 2025 in “ Journal of the Endocrine Society
    Ryan S.K. Wi, Lauren Calaza, Mikhail Torosoff
    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study observed that finasteride, while lowering cholesterol levels, did not decrease the prevalence of clinical cardiovascular events or new ECG abnormalities in men with benign prostatic hyperplasia compared to controls, suggesting a potential disconnect between cholesterol management and cardiovascular risk reduction with this treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →